NEW YORK (GenomeWeb) – Despite commercial attempts to develop noninvasive molecular tests that could serve as sentinels against the earliest signs of a developing cancer, there is still little data demonstrating that the most popular strategy— detecting changes in circulating DNA — is possible, let alone practical.